Increase Home-based dialysis in patients with kidney failure and CVD, recommends AHA Aug. 23, 2022, 8:31 a.m.
In patients with end-stage kidney disease, cardiovascular disease is the leading cause of morbidity and mortality. Currently, the most common therapy worldwide for patients with treated kidney failure. is thrice-weekly in-center hemodialysis for 3 to 5 hours per session. However, thrice-weekly in-center hemodialysis yields poor outcomes.
Variation in Peritoneal Dialysis Time on Therapy by Country July 25, 2022, 7:47 a.m.
Worldwide, among those receiving dialysis for end-stage kidney failure, 11% receivetreatment with peritoneal dialysis (PD) with the majority receiving facility-basedhemodialysis (HD). Recent initiatives have led to PD utilization increases in theUnited States. Quantifying how long patients remain on PD (i.e., time on therapy) isimportant for patients and providers. Here we have described: (1) time on PD in thecontext of outcomes of hemodialysis transfer (HDT), death, and kidneytransplantation, and (2) patient-level and practice pattern determinants of theseoutcomes, in 7 countries.
Spiritual Well-Being in Peritoneal Dialysis Patients and Its Link to Patient Characteristics July 14, 2022, 6:14 a.m.
Patients with chronic or terminal illnesses may find it easier to manage their conditions if they have a strong sense of their spiritual well-being (SWB) or their perception of the meaning and purpose of life. For a study, researchers evaluated SWB in patients with PD as well as its associations with patient features and outcomes as reported by patients (PRO).
Fatigue in incident peritoneal dialysis and mortality July 3, 2022, 8:19 a.m.
In summary, in this real-world multi-centric parallel analysis of nationally representative cohorts of incident PD patients in Brazil and the United States, we found that individuals who are more fatigued within 90 days of PD initiation had higher risks for all-cause mortality that was independent of key confounders.
Comparing the effect of peritoneal dialysis cycler type on patient-reported satisfaction, support needs and treatments July 3, 2022, 8:15 a.m.
Despite the difference in features provided between the 2 cyclers, patient overall satisfaction rates were high irrespective of the PD cycler. The HomeChoice Pro and AMIA cycler patients had a similar number of PD training days, PD-related telephone/office encounters, and PD-related emergency room visits/hospitalizations.
Cut the phosphorous, keep the protein – the dilemma of renal diets July 3, 2022, 8:10 a.m.
Chronic kidney disease (CKD) affects millions of people around the world. Diet is crucial for the best prognosis. At Mount Sinai Hospital in New York, CKD specialist Jaime Uribarri is planning to investigate the impact of a renal diet with low-phosphorous whey protein. If all goes well, kidney patients will gain a new dietary tool to help them live a satisfactory life.
The Benefits of More Frequent Home Dialysis July 2, 2022, 10:44 a.m.
At NxStage, we’ve seen first-hand how patients have enjoyed improved health and a better quality of life through more frequent home dialysis whether HHD or PD. But don’t take our word for it. Many studies have shown that the benefits of home dialysis go far beyond convenience.
How to take care of your catheter used in peritoneal dialysis. June 13, 2022, 11:53 a.m.
The utmost important and serious complication of peritoneal dialysis is infection around the access area. Which usually exists in skin or inside the abdominal area. Hernia is an another issue created by this procedure, weakness in the abdominal muscles.
Cost Barriers to More Widespread Use of Peritoneal Dialysis in the United States June 6, 2022, 1:11 p.m.
By offering policy suggestions that include improving data collection to better understand costs in peritoneal dialysis, and sharing potential savings among all stakeholders, to incentivize a transition to peritoneal dialysis.
Hidden Costs Associated with Conversion from Peritoneal Dialysis to Hemodialysis June 6, 2022, 1:10 p.m.
The transition from PD to HD is characterized by high rates of acute-care encounters and health-care expenditures. Quality improvement efforts should be aimed at improving transitions and encouraging both home HD and kidney transplantation after PD discontinuation.
Diabetics with low HDL-C levels prone to peritoneal dialysis-related peritonitis May 30, 2022, 6:37 a.m.
Over the past year, one IoT industry segment has received a notable—and necessary—amount of cybersecurity scrutiny, standing in stark contrast to the rest of the market: connected medical devices and equipment. Where the manufacturers of Wi-Fi connected speakers may not be too concerned with security standards, connected medical device manufacturers are facing regulatory pressures to hold themselves to a higher standard.
The incidence of pain and its association with quality of life in patients with peritoneal dialysis May 9, 2022, 9:14 a.m.
The incidence of pain in PD patients was 33.1%. Older age and higher intact parathyroid hormone level were independent risk factors for pain. Pain was independently associated with depressive symptoms, sleep quality and quality of life in PD patients.
Quality of life in peritoneal dialysis patients: Decline over time and association with clinical outcomes May 9, 2022, 9:14 a.m.
Quality of life declines in patients on PD over time. Certain aspects of QoL are especially poor in Asian and male patients. This study suggests that further research is necessary to determine the effects of interventions directed at enhancing emotional and social support.
Bioimpedance spectroscopy: Is a picture worth a thousand words? May 2, 2022, 7:42 a.m.
Volume status can be difficult to assess in dialysis patients. Peripheral edema, elevated venous pressure, lung crackles, and hypertension are taught as signs of fluid overload, but sensitivity and specificity are poor. Bioimpedance technology has evolved from early single frequency to multifrequency machines which apply spectroscopic analysis (BIS), modeling data to physics-based mixture theory. Bioimpedance plots can aid the evaluation of hydration status and body composition. The challenge remains how to use this information to manage dialysis populations, particularly as interventions to improve over hydration, sarcopenia, and adiposity are not without side effects. It is therefore of no surprise that validation studies for BIS use in peritoneal dialysis patients are limited, and results from clinical trials are inconsistent and conflicting. Despite these limitations, BIS has clinical utility with potential to accurately evaluate small changes in body tissue components. This article explains the information a BIS plot ("picture") can provide and how it can contribute to the overall clinical assessment of a patient. However, it remains the role of the clinician to integrate information and devise treatment strategies to optimize competing patient risks, fluid and nutrition status, effects of high glucose PD fluids on membrane function, and quality of life issues.
What is BIS? May 2, 2022, 7:40 a.m.
Bioimpedance spectroscopy (BIS) is the only noninvasive, low-cost technology that can accurately measure a patient’s total body water, extracellular and intracellular fluid volumes in a clinical setting. This detailed data can help healthcare professionals with early detection, assessment and interventions for chronic conditions.
The best part about Peritoneal Dialysis is that it is continuous April 18, 2022, 7:09 a.m.
PD is a continuous therapy. It is happening all the time. The fluid in the peritoneal cavity is filtering out excess water from the blood continuously.
Continuous ambulatory peritoneal dialysis. Patient and method survival rate, peritonitis incidence and dialysis efficacy over 10 years April 11, 2022, 12:59 p.m.
From 1979 to 1989, continuous ambulatory peritoneal dialysis (CAPD) was undertaken for terminal renal failure in 104 patients (56 women and 48 men; average age 54 +/- 15.3 years at the onset of dialysis), for a total observation period of 175 patients years. Survival rate for patients and methods and dialysis effectiveness were analysed retrospectively, the incidence of peritonitis prospectively, 40 patients were aged 60 years and over.
The Underrated Role of Ultrasound in Peritoneal Dialysis April 4, 2022, 7:39 a.m.
Ultrasound is very effective in performing procedures and assessment of complications in peritoneal dialysis. The ultrasound examination can be applied for preoperative assessment, during the peritoneal catheter placement, for the detection and monitoring of infection, as well as for the evaluation of the catheter malfunction. Despite being not only a cost- and time-saving technique but also a bedside procedure, ultrasonography remains an underrated clinical tool in the field of peritoneal dialysis. This publication wants to explain and reinforce the clinical utility of US in PD and to expand the diagnostic equipment for the clinician.